Danaher Corporation $DHR Stock Sold by Calamos Wealth Management LLC

Key Points

• Calamos Wealth Management cut its Danaher stake by 93.1% in the third quarter, selling 58,791 shares and retaining 4,344 shares valued at about $962,000.
• Analysts remain broadly positive: 18 rate Danaher a Buy and five a Hold, for a “Moderate Buy” consensus and an average price target of $242.91.
• Danaher reported quarterly EPS of $2.11, beating the $1.92 consensus, while revenue rose 8.3% year over year to $6.55 billion.

Calamos Wealth Management LLC trimmed its position in Danaher Corporation (NYSE:DHR - Free Report) by 93.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,344 shares of the conglomerate's stock after selling 58,791 shares during the period. Calamos Wealth Management LLC's holdings in Danaher were worth $962,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Calamos Advisors LLC increased its position in Danaher by 0.8% during the 3rd quarter. Calamos Advisors LLC now owns 222,372 shares of the conglomerate's stock valued at $49,267,000 after buying an additional 1,701 shares in the last quarter. Alta Advisers Ltd raised its stake in Danaher by 86.0% in the third quarter. Alta Advisers Ltd now owns 4,525 shares of the conglomerate's stock valued at $1,003,000 after buying an additional 2,092 shares during the last quarter. Legacies Wealth LLC purchased a new stake in Danaher in the third quarter valued at about $83,000. Principle Wealth Partners LLC boosted its holdings in Danaher by 5.5% in the third quarter. Principle Wealth Partners LLC now owns 5,015 shares of the conglomerate's stock worth $1,111,000 after acquiring an additional 263 shares in the last quarter. Finally, Kestra Advisory Services LLC boosted its holdings in Danaher by 4.9% in the third quarter. Kestra Advisory Services LLC now owns 78,390 shares of the conglomerate's stock worth $17,367,000 after acquiring an additional 3,643 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on DHR. TD Cowen upped their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a "buy" rating in a report on Thursday, October 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Stifel Nicolaus boosted their target price on shares of Danaher from $220.00 to $260.00 and gave the stock a "buy" rating in a research report on Thursday, October 22nd. Robert W. Baird upped their price target on shares of Danaher from $246.00 to $254.00 and gave the company an "outperform" rating in a research note on Thursday, October 22nd. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $275.00 price target on shares of Danaher in a report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $242.91.

Insider Activity

In related news, CAO Christopher Bouda sold 7,598 shares of the business's stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 10.80% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of NYSE DHR opened at $230.34 on Friday. The business's 50 day moving average price is $220.27 and its 200 day moving average price is $201.60. The firm has a market cap of $162.05 billion, a P/E ratio of 37.70, a P/E/G ratio of 2.89 and a beta of 0.76. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. During the same period last year, the firm posted $1.89 EPS. Danaher's revenue for the quarter was up 8.3% compared to the same quarter last year. On average, sell-side analysts expect that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio is presently 26.19%.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company's businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.